Rafael Holdings, Inc.

Real Estate · Real Estate Services · United States

Last price 1.12 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 58.24M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel. It operates in three segments, Healthcare, Infusion Technology, and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is Trappsol Cyclo, which is in phase 3 clinical trial being evaluated for the potential treatment of Niemann-Pick Disease Typ...